Adopting a private equity–style discipline for clinical trial due diligence

by Arthur D. Little

Clinical trials are among biopharma’s most significant investments, yet many still advance on internal optimism rather than external validation. In contrast, private equity (PE) firms apply structur...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Suma Capital strengthens Gestcompost to ...

by Suma Capital

Since Suma Capital’s entry in 2020, Gestcompost has quadrupled its E...

Photos Stream